Article
Metastatic NUT Midline Carcinoma Treated With Aggressive Neoadjuvant Chemotherapy, Radiation, and Resection: A Case Report and Review of the Literature.
Journal of pediatric hematology/oncology - 1 Jan 2021
Sopfe Jenna, Greffe Brian, Treece Amy L
Abstract excerpt
NUT midline carcinoma, characterized by the rearrangement of the nuclear protein in testis (NUTM1) gene, is a rare and aggressive subtype of squamous cell carcinoma. This disease is rarely cured and there have been no reports of cure in patients with distant metastatic disease. In fact, patients typically succumb to NUT midline carcinoma within 6 to 12 months from diagnosis. The authors report on a single patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
